|
Psoriasis
Citations 31-40 of 196 total displayed.
|
Past content
(since Jan 1998):
|
- Correspondence
The Role of Narrowband UV-B Plus Alefacept Combination Therapy in the Treatment of Psoriasis
- Heidi Jacobe; Laura Winterfield; Flora Kim; Beverley Huet-Adams; Rachael Cayce
Arch Dermatol 2008; 144: 1067-1068.
[Extract]
[Full text]
[PDF]
- Correspondence
The Role of Narrowband UV-B Plus Alefacept Combination Therapy in the Treatment of Psoriasis—Reply
- Franz J. Legat; Franz Quehenberger; Peter Wolf
Arch Dermatol 2008; 144: 1068-1069.
[Extract]
[Full text]
[PDF]
- Correspondence
The Use of Patch Tests in Determining Hypersensitivity to Etanercept and Infliximab
- Lidian L. A. Lecluse; Gamze Piskin; Jan D. Bos
Arch Dermatol 2008; 144: 1070-a-1071-a.
[Extract]
[Full text]
[PDF]
- Correspondence
The Use of Patch Tests in Determining Hypersensitivity to Etanercept and Infliximab—Reply
- Julien Seneschal; Brigitte Milpied; Alain Taïeb
Arch Dermatol 2008; 144: 1071-1072.
[Extract]
[Full text]
[PDF]
- Research Letters
Sustained Efficacy and Safety of Adalimumab in Psoriasis Treatment: A Retrospective Study of 49 Patients With and Without a History of TNF- Antagonist Treatment
- Livia Van; Sapna V. Modi; Deborah J. Yang; Sylvia Hsu
Arch Dermatol 2008; 144: 804-806.
[Extract]
[Full text]
[PDF]
- Research Letters
Efficacy and Safety of Chaperonin 10 in Patients With Moderate to Severe Plaque Psoriasis: Evidence of Utility Beyond a Single Indication
- Bronwyn Williams; Daina Vanags; Stephen Hall; Chris McCormack; Peter Foley; Julissa Weiss; Barbara Johnson; Eicke Latz; Dennis Feeney
Arch Dermatol 2008; 144: 683-685.
[Extract]
[Full text]
[PDF]
- The Cutting Edge
Successful Treatment With Etanercept of von Zumbusch Pustular Psoriasis in a Patient With Human Immunodeficiency Virus
- Maryann Mikhail; Jeffrey M. Weinberg; Barry L. Smith
Arch Dermatol 2008; 144: 453-456.
[Extract]
[Full text]
[PDF]
- Commentaries
Time to Nip "Seeding Trials" in the Bud
- Kenneth A. Katz
Arch Dermatol 2008; 144: 403-404.
[Extract]
[Full text]
[PDF]
- Studies
Safety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis: Results of a Randomized, Placebo-Controlled, Phase 2 Trial
- Alexa B. Kimball; Kenneth B. Gordon; Richard G. Langley; Alan Menter; Elliot K. Chartash; Joaquin Valdes; for the ABT-874 Psoriasis Study Investigators
Arch Dermatol 2008; 144: 200-207.
[Abstract]
[Full text]
[PDF]
- Off-Center Fold
Psoriasiform Eruption and Pharyngitis—Diagnosis
-
Arch Dermatol 2008; 144: 255-g-260-g.
[Extract]
[Full text]
[PDF]
|
|
